An investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon pathways. Current research focuses on metabolic signaling, glucose regulation, energy balance, and related cardiometabolic markers.
An investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon pathways. Current research focuses on metabolic signaling, glucose regulation, energy balance, and related cardiometabolic markers.